Skip Navigation

Cardiovascular Research 1995 29(6):848-855; doi:10.1016/S0008-6363(96)88622-6
© 1995 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kirschenlohr, H. L
Right arrow Articles by Grainger, D. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kirschenlohr, H. L
Right arrow Articles by Grainger, D. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1995, European Society of Cardiology

Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGFβ

Heide L Kirschenlohr*,a, James C Metcalfea, Peter L Weissbergb,1 and David J Graingera,2

aDepartment of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge CB2 1QW, United Kingdom
bSchool of Clinical Medicine, University of Cambridge, Hills Road, Cambridge, UK

* Correspondence to Dr Kirschenlohr.

Objective: Human vascular smooth muscle cells (VSMC) prepared by enzyme dispersal have been reported to proliferate more slowly and remain more differentiated than VSMC derived by explant culture. The aim of this study was to investigate whether these differences are attributable to the production of transforming growth factor β (TGFβ), a major modulator of VSMC properties in culture, by enzyme dispersal, but not explant, cultures. Methods: Human aortic VSMC cultures were prepared by enzymatic dissociation of aortic media or by outgrowth of cells from explants derived from the vessel media. Properties, including rate of proliferation and differentiation, of the two different types of culture obtained from 10 donors (age 3–54 years, of either sex) were compared. The role of TGFβ as mediator of these differences was investigated. Results: VSMC from enzyme dispersal cultures proliferated with a long doubling time in 20% fetal calf serum of 68(SEM 2) h, reaching a low saturation density with no "hills and valleys", and the cells were predominantly of stellate morphology. VSMC from explant cultures proliferated with a shorter doubling time of 35(2) h, reached a higher saturation density with "hills and valleys", and showed a spindle shaped morphology. The enzyme dispersed cells, but not the explant cells, released TGFβ into the medium. Addition of exogenous TGFβ to the explant cells extended the doubling time, while addition of a neutralising antibody to the enzyme dispersed cells decreased the doubling time. Tamoxifen, an anti-oestrogenic drug, decreased the rate of proliferation of the explant cells (ED50 = 50 nM; n = 3) but not enzyme dispersed cells by stimulating production of TGFβ. The explant and enzyme dispersal cultures also differed in response to growth factors. The explant cultures stimulated DNA synthesis in response to platelet derived growth factor (PDGF) AA and BB. Enzyme dispersal cultures stimulated DNA synthesis in response to PDGF-BB but response to AA was weaker and also variable. Conclusions: Human explant derived VSMC systematically differ from enzyme dispersed VSMC obtained from the same donor tissue. Wherever the potential role of TGFβ was investigated, the differences between enzyme dispersal and explant cultures were due to autocrine production of TGFβ by the enzyme dispersal, but not explant cultures.

KEYWORDS human aorta; explant cultures; enzyme dispersed cell cultures; transforming growth factor β; vascular smooth muscle cells


1 PLW is a British Heart Foundation Senior Research Fellow.

2 DJG is the recipient of a Wellcome Prize Fellowship.

{star} This work was supported by a British Heart Foundation group grant and a grant from Glaxo Group Research to PLW and JCM.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. C Newby and A. B Zaltsman
Fibrous cap formation or destruction -- the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation
Cardiovasc Res, February 1, 1999; 41(2): 345 - 360.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.